Loss of Smad7 can enhance susceptibility to HCC, and SMAD7 suppresses HCC cell growth by inhibiting proliferation and G1-S phase transition and inducing apoptosis through attenuation of NFKB and TGFβ signaling [33]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.